Lv1
30 积分 2026-08-10 加入
First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults
1天前
已完结
RhPro-UK in acute ischemic stroke within 4.5 h of stroke onset trial-2 (the PROST-2 study): Rationale and design of a multicenter, prospective, randomized, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
1天前
已完结
Current gaps in acute reperfusion therapies
1天前
已完结
皖公网安备34019202002308
